Surgical Innovations Group plc (SUN.L)

0.5500 0.0000 (0.00%) At close: 02:31PM BST

Surgical Innovations Group plc

Clayton Wood House
6 Clayton Wood Bank
Leeds LS16 6QZ
United Kingdom
44 11 3230 7597
https://www.sigroupplc.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 80

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. David John Marsh	CEO & Director	219k	N/A	1964
Mr. Christopher Jonathan Martin	CFO & Executive Director	N/A	N/A	1968
Mr. Alex Hogg	Operations Director	N/A	N/A	N/A
Mr. Stephen Seed	Chief Compliance Officer	N/A	N/A	N/A
Julia Horrocks Taylor	HR Director	N/A	N/A	N/A
Mr. Damian Donnelly	Chief Commercial Officer	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company offers YelloPort Elite port access systems; YelloPort +plus Resposable port access systems; LogiCut, a disposable laparoscopic insert; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. It also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and build of instruments. In addition, the company distributes specialist medical products; and designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. The company was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.

Corporate Governance

Surgical Innovations Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.